Personal tools

MCL coexpression mm9:1343: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0004177!4.05e-15!29;UBERON:0005057!4.05e-15!29;UBERON:0001041!1.48e-14!80;UBERON:0002390!3.80e-14!45;UBERON:0003061!3.80e-14!45;UBERON:0002193!1.18e-13!48;UBERON:0002405!1.18e-13!48;UBERON:0003408!1.12e-11!24;UBERON:0000077!1.61e-11!35;UBERON:0002370!3.47e-11!23;UBERON:0000974!3.47e-11!23;UBERON:0004807!3.47e-11!23;UBERON:0005058!3.47e-11!23;UBERON:0003351!3.47e-11!23;UBERON:0009113!3.47e-11!23;UBERON:0003295!3.47e-11!23;UBERON:0009722!3.47e-11!23;UBERON:0005562!3.47e-11!23;UBERON:0007690!3.47e-11!23;UBERON:0001004!1.03e-10!42;UBERON:0006562!2.28e-10!24;UBERON:0001557!2.28e-10!24;UBERON:0001042!2.28e-10!24;UBERON:0008814!2.28e-10!24;UBERON:0009145!2.28e-10!24;UBERON:0000065!2.95e-10!41;UBERON:0004921!7.68e-10!114;UBERON:0005911!1.19e-09!69;UBERON:0001007!2.58e-09!116;UBERON:0001555!2.58e-09!116;UBERON:0007026!2.58e-09!116;UBERON:0004119!8.17e-09!118;UBERON:0000925!8.17e-09!118;UBERON:0006595!8.17e-09!118;UBERON:0000072!2.54e-08!27;UBERON:0002530!2.94e-08!65;UBERON:0002368!8.63e-08!60;UBERON:0003081!1.08e-07!87;UBERON:0001048!1.18e-07!134;UBERON:0003929!2.09e-07!55;UBERON:0000475!9.37e-07!150
|ontology_enrichment_uberon=UBERON:0004177!4.05e-15!29;UBERON:0005057!4.05e-15!29;UBERON:0001041!1.48e-14!80;UBERON:0002390!3.80e-14!45;UBERON:0003061!3.80e-14!45;UBERON:0002193!1.18e-13!48;UBERON:0002405!1.18e-13!48;UBERON:0003408!1.12e-11!24;UBERON:0000077!1.61e-11!35;UBERON:0002370!3.47e-11!23;UBERON:0000974!3.47e-11!23;UBERON:0004807!3.47e-11!23;UBERON:0005058!3.47e-11!23;UBERON:0003351!3.47e-11!23;UBERON:0009113!3.47e-11!23;UBERON:0003295!3.47e-11!23;UBERON:0009722!3.47e-11!23;UBERON:0005562!3.47e-11!23;UBERON:0007690!3.47e-11!23;UBERON:0001004!1.03e-10!42;UBERON:0006562!2.28e-10!24;UBERON:0001557!2.28e-10!24;UBERON:0001042!2.28e-10!24;UBERON:0008814!2.28e-10!24;UBERON:0009145!2.28e-10!24;UBERON:0000065!2.95e-10!41;UBERON:0004921!7.68e-10!114;UBERON:0005911!1.19e-09!69;UBERON:0001007!2.58e-09!116;UBERON:0001555!2.58e-09!116;UBERON:0007026!2.58e-09!116;UBERON:0004119!8.17e-09!118;UBERON:0000925!8.17e-09!118;UBERON:0006595!8.17e-09!118;UBERON:0000072!2.54e-08!27;UBERON:0002530!2.94e-08!65;UBERON:0002368!8.63e-08!60;UBERON:0003081!1.08e-07!87;UBERON:0001048!1.18e-07!134;UBERON:0003929!2.09e-07!55;UBERON:0000475!9.37e-07!150
|tfbs_overrepresentation_for_novel_motifs=0.491922,0.473747,0.464605,0.535892,0.346849,0.550971,0.645383,0.247459,0.257202,0.0835344,0.599767,1.53013,0.247704,0.6581,0.364314,0,0.856992,0.338549,0.232269,0.143775,0.426133,0.35122,0.657163,0.345236,0.472505,0.686615,0.223823,0.572827,0.394364,0.181062,0.558142,0.960397,0.336199,0.204204,0.364821,0.335531,0.326478,0.629145,0.820134,0.752287,0.342638,0.56353,0.0995018,0.366415,0.161543,0.524258,0.77511,0.589246,0.284064,0.397446,0.839084,0.714419,0.517905,1.10437,1.12205,0.66551,0.406788,0.619643,0.21472,0.663395,0.939962,0.724164,0.269393,0.827522,0.677043,0.869046,1.2599,1.61148,0.935192,1.46355,0.444872,0.70565,0.11437,1.156,0.208101,0.57254,0.204132,0.763395,0.922432,0.430551,0.254777,0.874787,0.722675,0.240896,1.03903,0.0539203,0.0610418,0.181203,0.780154,1.77427,1.33021,1.04409,0.973447,0.35304,0.2995,0.281222,0.685716,0.976308,0.775372,0.160254,0.326561,0.960112,1.08669,0.839694,0.838613,0.563071,0.8998,0.585058,0.435642,0.428007,0.484547,1.0885,0.431734,0.605144,1.33732,0.340765,0.0704207,0.53982,1.99662,0.322606,1.16147,0.805995,0.688501,0.762461,1.39185,0.926209,0.65384,0.966541,1.25836,0.356163,1.06946,0.52828,1.2285,0.679647,1.35909,0.106956,1.25097,0.564999,1.30952,2.14327,1.74232,1.26465,0.700956,0.971067,0.831964,0.564002,0.778321,2.10357,1.25623,0.348692,0.183562,0.0987301,1.10596,0.287383,0.678689,1.18867,0.71546,0.376898,0.48935,0.500417,1.31911,1.03816,0.926663,0.482185,0.82857,0.671017,0.86867,0.63125,0.30995
}}
}}

Revision as of 19:46, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr13:41455246..41455250,-p@chr13:41455246..41455250
-
Mm9::chr13:41518596..41518612,-p@chr13:41518596..41518612
-
Mm9::chr2:166521253..166521257,-p@chr2:166521253..166521257
-
Mm9::chr2:43787696..43787699,+p@chr2:43787696..43787699
+
Mm9::chr2:43809789..43809795,+p@chr2:43809789..43809795
+
Mm9::chr4:149071956..149071965,-p@chr4:149071956..149071965
-


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


no results for this coexpression

Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Cell Type
Ontology termp-valuen
lymphoid lineage restricted progenitor cell1.67e-0712
hematopoietic lineage restricted progenitor cell2.11e-0725
T cell7.11e-0711
pro-T cell7.11e-0711

Uber Anatomy
Ontology termp-valuen
hemopoietic organ4.05e-1529
immune organ4.05e-1529
foregut1.48e-1480
hematopoietic system3.80e-1445
blood island3.80e-1445
hemolymphoid system1.18e-1348
immune system1.18e-1348
gland of gut1.12e-1124
mixed endoderm/mesoderm-derived structure1.61e-1135
thymus3.47e-1123
neck3.47e-1123
respiratory system epithelium3.47e-1123
hemolymphoid system gland3.47e-1123
pharyngeal epithelium3.47e-1123
thymic region3.47e-1123
pharyngeal gland3.47e-1123
entire pharyngeal arch endoderm3.47e-1123
thymus primordium3.47e-1123
early pharyngeal endoderm3.47e-1123
respiratory system1.03e-1042
pharynx2.28e-1024
upper respiratory tract2.28e-1024
chordate pharynx2.28e-1024
pharyngeal arch system2.28e-1024
pharyngeal region of foregut2.28e-1024
respiratory tract2.95e-1041
subdivision of digestive tract7.68e-10114
endo-epithelium1.19e-0969
digestive system2.58e-09116
digestive tract2.58e-09116
primitive gut2.58e-09116
endoderm-derived structure8.17e-09118
endoderm8.17e-09118
presumptive endoderm8.17e-09118
segment of respiratory tract2.54e-0827
gland2.94e-0865
endocrine gland8.63e-0860
lateral plate mesoderm1.08e-0787
primordium1.18e-07134
gut epithelium2.09e-0755
organism subdivision9.37e-07150


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}